Novel genomic loci influencing plasma homocysteine levels

Stroke

Volumn 37, Issue 7, 2006, Pages 1703-1709

  Kullo, Iftikhar J ^a   Ding, Keyue ^a   Boerwinkle, Eric ^b   Turner, Stephen T ^a   Mosley, Thomas H ^c   Kardia, Sharon L R ^d   De Andrade, Mariza ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Genetic linkage; Homocysteine; Stroke

Indexed keywords

ESTROGEN; HOMOCYSTEINE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1; COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CREATININE; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; GAMT PROTEIN, HUMAN; GUANIDINOACETATE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; AUTOSOME; BODY MASS; CHROMOSOME 14Q; CHROMOSOME 19P; CHROMOSOME 1Q; CHROMOSOME 9Q; CREATININE BLOOD LEVEL; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENOTYPE; HERITABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; AFRICAN AMERICAN; AGE; BLOOD; CAUCASIAN; CHROMOSOME MAP; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; GENETICS; HUMAN CHROMOSOME; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AFRICAN AMERICANS; AGE FACTORS; AGED; BODY MASS INDEX; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; COHORT STUDIES; CREATININE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GUANIDINOACETATE N-METHYLTRANSFERASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LOD SCORE; MALE; MIDDLE AGED; PROTEIN-ARGININE N-METHYLTRANSFERASE; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 33745941419     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000225929.96190.b3     Document Type: Article

References (39)

1. McCully KS. Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: A key case revisited. Nutr Rev. 1992;50:7-12.
2. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042-1050.
3. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165-176.
4. Kullo IJ, Li G, Bielak LF, Bailey KR, Sheedy PFI, Peyser PA, Turner ST, Kardia SLR. Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk. Mayo Clin Proc. 2006;81:177-182.
5. Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A. Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke. 2001;32:2753-2758.
6. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study. Ann Intern Med. 1999;131:352-355.
7. Homocystein Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA. 2002;288:2015-2022.
8. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
9. Wilson A, Leclerc D, Saberi F, Campeau E, Hwang HY, Shane B, Phillips JA 3rd, Rosenblatt DS, Gravel RA. Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency. Am J Hum Genet. 1998;63:409-414.
10. Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordonez-Llanos J, Martin-Campos JM, Lathrop M, Stone W, Blangero J, Fontcuberta J. A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: Results from the GAIT project. Am J Hum Genet. 2005;76:925-933.
11. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM, Whitehead AS. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood. 2003;101:2483-2488.
12. Jee SH, Song KS, Shim WH, Kim HK, Suh I, Park JY, Won SY, Beaty TH. Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Hum Genet. 2002;111:128-135.
13. Lerner-Ellis JP, Tirone JC, Pawelek PD, Dore C, Atkinson JL, Watkins D, Morel CF, Fujiwara TM, Moras E, Hosack AR, Dunbar GV, Antonicka H, Forgetta V, Dobson CM, Leclerc D, Gravel RA, Shoubridge EA, Coulton JW, Lepage P, Rommens JM, Morgan K, Rosenblatt DS. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet. 2006;38:93-100.
14. The FBPP Investigators. Multi-center genetic study of hypertension: The Family Blood Pressure program (FBPP). Hypertension. 2002;39:3-9.
15. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004;164:1313-1318.
16. Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247.
17. O'Connell JR, Weeks DE. Pedcheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63:259-266.
18. de Andrade M, Fridley B, Boerwinkle E, Turner ST. Diagnostic tools in linkage analysis for quantitative traits. Genet Epidemiol. 2003;24:302-308.
19. de Andrade M, Lunde E, Atkinson E, Amos CI, Chen J. An S-plus/R library for quantitative trait linkage analysis. Am Society of Human Genetics. 2005. Salt Lake City, UT, October 25-29, 2005 (abstract 2325).
20. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54:535-543.
21. de Andrade M, Thiel TJ, Yu L, Amos CI. Assessing linkage on chromosome 5 using components of variance approach: Univariate versus multivariate. Genet Epidemiol. 1997;14:773-778.
22. Sobel E, Sengul H, Weeks DE. Multipoint estimation of identity-bydescent probabilities at arbitrary positions among marker loci on general pedigrees. Hum Hered. 2001;52:121-131.
23. Morton NE. Significance levels in complex inheritance. Am J Hum Genet. 1998;62:690-697.
24. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, eds. Homocysteine in Health and Disease. Cambridge, United Kingdom: Cambridge University Press; 2001.
25. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
26. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483.
27. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002;33:2351-2356.
28. Troen A, Rosenberg I. Homocysteine and cognitive function. Semin Vasc Med. 2005;5:209-214.
29. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000;101:1546-1551.
30. den Heijer M, Graafsma S, Lee SY, van Landeghem B, Kluijtmans L, Verhoef P, Beaty TH, Blom H. Homocysteine levels-before and after methionine loading - in 51 Dutch families. Eur J Hum Genet. 2005;13:753-762.
31. Swanson DA, Liu ML, Baker PJ, Garrett L, Stitzel M, Wu J, Harris M, Banerjee R, Shane B, Brody LC. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol. 2001;21:1058-1065.
32. Watkins D, Ru M, Hwang HY, Kim CD, Murray A, Philip NS, Kim W, Legakis H, Wai T, Hilton JF, Ge B, Dore C, Hosack A, Wilson A, Gravel RA, Shane B, Hudson TJ, Rosenblatt DS. Hyperhomocysteinemia due to methionine synthase deficiency, cblG: Structure of the mtr gene, genotype diversity, and recognition of a common mutation, P1173L. Am J Hum Genet. 2002;71:143-153.
33. Noga AA, Stead LM, Zhao Y, Brosnan ME, Brosnan JT, Vance DE. Plasma homocysteine is regulated by phospholipid methylation. J Biol Chem. 2003;278:5952-5955.
34. Gaustadnes M, Rudiger N, Rasmussen K, Ingerslev J. Familial thrombophilia associated with homozygosity for the cystathionine β-synthase 833T→C mutation. Arterioscler Thromb Vasc Biol. 2000;20:1392-1395.
35. Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, Brosnan JT. Hormonal regulation of cystathionine β-synthase expression in liver. J Biol Chem. 2002;277:42912-42918.
36. Vermeulen HHM, van der Vleuten GM, de Graaf J, Blom HJ, Hermus AR, Stalenhoef AF, den Heijer M. A genome-wide linkage scan for homocysteine levels identifies three regions of interest. J Thromb Haemost. 2005;3 (Suppl 1):abstract OR127.
37. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: Contribution of income and other risk factors among men screened for the MRFIT. MRFIT research group. Multiple Risk Factor Intervention Trial. Lancet. 1998;351:934-939.
38. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, Woo D, Szaflarski J, Gebel J, Moomaw C, Pancioli A, Jauch E, Shukla R, Broderick J. Stroke in a biracial population: The excess burden of stroke among blacks. Stroke. 2004;35:426-431.
39. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Eng J Med. 1999;340:1449-1454.